Cargando...
Low levels of cerebrospinal fluid complement 3 and factor H predict faster cognitive decline in mild cognitive impairment
INTRODUCTION: Alzheimer’s disease (AD) is characterized by the deposition of tau and amyloid in the brain. Although the core cerebrospinal fluid (CSF) AD biomarkers amyloid β peptide 1–42 (Aβ(1–42)), total tau (t-tau) and phosphorylated tau 181 (p-tau(181)) show good diagnostic sensitivity and speci...
Gardado en:
| Publicado en: | Alzheimers Res Ther |
|---|---|
| Main Authors: | , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
BioMed Central
2014
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4255518/ https://ncbi.nlm.nih.gov/pubmed/25478014 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/alzrt266 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|